Chromatography Data Systems Directory

Software for acquiring, processing, and reporting chromatography data, used by analytical chemists, lab managers, and QA teams in regulated environments.

Browse software
OVERVIEW

About Chromatography Data Systems

Chromatography Data Systems sit at the junction between analytical instruments and the regulated data record. They handle acquisition from LC, GC, and HPLC hardware, apply integration and calibration, manage method and sequence libraries, and produce reviewable results that downstream QA, manufacturing, and regulatory functions can sign off on. The operational tension in this category is well understood: instrument control wants to live close to the bench, while data review, archival, and audit obligations push toward centralised governance. Analytical chemists, lab managers, and QA reviewers are the day-to-day users, and their workflows are shaped less by feature novelty than by instrument driver coverage, validation overhead, and how cleanly results move into adjacent LIMS or ELN systems.

Two patterns stand out in the current directory. Deployment is heavily on-premise — roughly three quarters of listed CDS products run locally, with hybrid arrangements making up most of the remainder and pure SaaS still a small share. That reflects the reality of instrument-coupled acquisition and the cost of revalidating cloud-hosted environments. The second signal is compliance density: more than half of the category explicitly covers 21 CFR Part 11, and around 40% address broader GxP scope, consistent with a user base concentrated in pharma, biotech, and CRO settings. AI-assisted features appear in only a handful of options so far.

IN OUR DATABASE

Browse Chromatography Software

FREQUENTLY ASKED QUESTIONS

Common Questions About Chromatography Data Systems

What are Chromatography Data Systems?

Chromatography Data Systems, commonly called CDS, are the control and data layer sitting between chromatography instruments — LC, GC, HPLC and related detectors — and the analytical record. They acquire raw signals, apply integration and calibration, manage methods and sequences, and produce reviewable, auditable results. In regulated labs, the CDS is also the system of record for chromatographic data, holding the audit trail, electronic signatures, and review workflows that downstream QA and regulatory functions depend on.

What should I look for when choosing a CDS?

Instrument driver coverage is usually the first filter — a system that cannot control your existing detectors and autosamplers is a non-starter. After that, evaluate method and sequence handling, peak integration logic, audit trail granularity, user role management, and how results flow into LIMS or ELN. For multi-site labs, look at networked acquisition, central library management, and how the vendor handles validation packages during version upgrades.

How do CDS platforms handle 21 CFR Part 11 and GxP requirements?

Most options in this category are built around Part 11 and GxP expectations rather than treating them as add-ons. Typical features include enforced electronic signatures, immutable audit trails covering acquisition and reprocessing, role-based access, and controlled method versioning. Buyers in pharma and biotech generally expect the vendor to supply validation documentation, IQ/OQ scripts, and a clear position on data integrity controls such as ALCOA+ alignment.

Why are most Chromatography Data Systems still deployed on-premise?

The category leans heavily on-premise because acquisition is tightly coupled to physical instruments, and labs are reluctant to put instrument control in the path of network or cloud latency. Validation effort, qualified infrastructure, and the cost of revalidating after migration also slow cloud adoption. Hybrid arrangements — local acquisition with centralised review, reporting, or archival — are more common than fully SaaS deployments in regulated environments.

How does a CDS differ from a LIMS or ELN?

A LIMS manages samples, workflows, and results across many instrument types; an ELN captures experimental context and decisions. A CDS is narrower and deeper: it controls chromatography hardware and owns the chromatogram itself, from raw signal through integrated peaks to a signed result. In practice, the three coexist, with the CDS pushing reviewed results into the LIMS and, in some workflows, contextual data into the ELN.

EXPLORE MORE

Other subdomains within Scientific Informatics & Analytical Platforms

Assay & Screening Data Management

Platforms managing the end-to-end lifecycle of biological assays and screening campaigns -- assay registration, compound tracking, results consolidation, and CRO coordination.

Biologics & Sequence Informatics

Platforms for sequence analysis, biological registration, antibody and protein data management, and multimodal biologics research workflows.

Chemical Informatics & Molecular Design

Software for drawing, registering, searching, and computationally designing chemical structures to support medicinal chemistry workflows from ideation through lead optimisation.

Integrated R&D Workflow Platforms

Software platforms unifying experiment documentation, chemical and biological design, data capture, analytics, and team collaboration across drug discovery and development.

Proteomics & Mass Spectrometry Analysis

Software for processing and interpreting mass spectrometry and proteomics data to identify, quantify, and characterise proteins, peptides, and biotherapeutics.

SELECTED COMPANIES

Companies with the largest Chromatography software portfolios

  • Mestrelab Research logo

    Mestrelab Research

    NMR, LC/GC-MS, and spectroscopy data processing with automation and ELN for analytical chemistry labs.

  • SciY logo

    SciY

    Instrument integration, data standardization, and AI-readiness for research, development, and manufacturing across biopharmaceuticals, materials science, and clinical labs.

  • Agilent Genomics software logo

    Agilent Genomics software

    Analytical instruments, cell analysis, and specialty CDMO services for life sciences discovery and diagnostics.